Clinical Trial Update: The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and effectiveness of rhTSH in radioiodine treatment for differentiated thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• rhTSH (recombinant human thyroid-stimulating hormone)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Differentiated Thyroid Cancer | Phase 2 | Status: UNKNOWN